Skip to main content
Erschienen in: International Urogynecology Journal 3/2014

01.03.2014 | Original Article

Long-term efficacy of electrical pudendal nerve stimulation for urgency–frequency syndrome in women

verfasst von: Siyou Wang, Shujing Zhang, Lin Zhao

Erschienen in: International Urogynecology Journal | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Electrical pudendal nerve stimulation (EPNS) was developed by combining the advantages of pudendal neuromodulation (PNM) and percutaneous tibial nerve stimulation (PTNS) and incorporating the technique of deep insertion of long acupuncture needles. The purpose of this study is to show the long-term efficacy of EPNS in treating urgency–frequency syndrome (UFS) in women.

Methods

One hundred and six consecutive female UFS patients were enrolled and treated with EPNS. Long acupuncture needles were deeply inserted into four sacral points and electrified to stimulate the pudendal nerves. Evaluation of therapeutic effects was based on a questionnaire (including questions on storage, voiding, and postmicturition symptoms). Patients with ≥50 % posttreatment symptom improvement were followed up for at least 60 months.

Results

Complete resolution and ≥50 % improvement rate were 42.5 % and 85.8 %, respectively, in the 106 patients after a mean of 21.2 sessions of EPNS treatment. Of the 91 patients with ≥50 % posttreatment improvement, 62 (29 with complete resolution, 15 with marked improvement, and 18 with moderate improvement) were available for follow-up at 60–126 (mean 99.5; median 98) months after the end of EPNS treatment. Of these 62 patients, 35 maintained the posttreatment effect, 18 changed from better to complete resolution, and seven changed back to <50 % improvement; only four of whom changed to <25 % improvement.

Conclusions

EPNS combines the advantages of PNM (better effect) and PTNS (minimally invasive, easily applicable, and well tolerated) in treating UFS. It has a good long-term therapeutic effect on UFS in women.
Literatur
1.
Zurück zum Zitat Bosch JL (2006) Electrical neuromodulatory therapy in female voiding dysfunction. BJU Int 98 (Suppl. 1):43–48 Bosch JL (2006) Electrical neuromodulatory therapy in female voiding dysfunction. BJU Int 98 (Suppl. 1):43–48
2.
Zurück zum Zitat van Balken MR, Vergunst H, Bemelmans BL (2004) The use of electrical devices for the treatment of bladder dysfunction: a review of methods. J Urol 172:846–851PubMedCrossRef van Balken MR, Vergunst H, Bemelmans BL (2004) The use of electrical devices for the treatment of bladder dysfunction: a review of methods. J Urol 172:846–851PubMedCrossRef
3.
Zurück zum Zitat Bemelmans BL, Mundy AR, Graggs MD (1999) Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol 36:81–91PubMedCrossRef Bemelmans BL, Mundy AR, Graggs MD (1999) Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol 36:81–91PubMedCrossRef
4.
Zurück zum Zitat Spinelli M, Sievert KD (2008) Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol 54:1287–1296PubMedCrossRef Spinelli M, Sievert KD (2008) Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol 54:1287–1296PubMedCrossRef
5.
Zurück zum Zitat Hijaz A, Vasavada S (2005) Complications and troubleshooting of sacral neuromodulation therapy. Urol Clin North Am 32:65–69PubMedCrossRef Hijaz A, Vasavada S (2005) Complications and troubleshooting of sacral neuromodulation therapy. Urol Clin North Am 32:65–69PubMedCrossRef
6.
Zurück zum Zitat Peters KM (2010) Alternative approaches to sacral nerve stimulation. Int Urogynecol J 21:1559–1563PubMedCrossRef Peters KM (2010) Alternative approaches to sacral nerve stimulation. Int Urogynecol J 21:1559–1563PubMedCrossRef
7.
Zurück zum Zitat Groen J, Amiel C, Bosch JL (2005) Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator. Neurourol Urodyn 24:226–230PubMedCrossRef Groen J, Amiel C, Bosch JL (2005) Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator. Neurourol Urodyn 24:226–230PubMedCrossRef
8.
Zurück zum Zitat Vasavada SP, Goldman HB, Rackley RR (2007) Neuromodulation techniques: a comparison of available and new therapies. Curr Urol Rep 8:455–460PubMedCrossRef Vasavada SP, Goldman HB, Rackley RR (2007) Neuromodulation techniques: a comparison of available and new therapies. Curr Urol Rep 8:455–460PubMedCrossRef
9.
Zurück zum Zitat Nuhoglu B, Fidan V, Ayyildiz A, Ersoy E, Germiyanoğlu C (2006) Stoller afferent nerve stimulation in woman with therapy resistant over active bladder; a 1-year follow up. Int Urogynecol J 17:204–207CrossRef Nuhoglu B, Fidan V, Ayyildiz A, Ersoy E, Germiyanoğlu C (2006) Stoller afferent nerve stimulation in woman with therapy resistant over active bladder; a 1-year follow up. Int Urogynecol J 17:204–207CrossRef
10.
Zurück zum Zitat Marchal C, Herrera B, Antuña F et al (2011) Percutaneous tibial nerve stimulation in treatment of overactive bladder: when should retreatment be started? Urology 78:1046–1050PubMedCrossRef Marchal C, Herrera B, Antuña F et al (2011) Percutaneous tibial nerve stimulation in treatment of overactive bladder: when should retreatment be started? Urology 78:1046–1050PubMedCrossRef
11.
Zurück zum Zitat Wang S, Zhang S (2012) Simultaneous perineal ultrasound and vaginal pressure measurement prove the action of electrical pudendal nerve stimulation in treating female stress incontinence. BJU Int 110:1338–1343PubMedCrossRef Wang S, Zhang S (2012) Simultaneous perineal ultrasound and vaginal pressure measurement prove the action of electrical pudendal nerve stimulation in treating female stress incontinence. BJU Int 110:1338–1343PubMedCrossRef
12.
Zurück zum Zitat Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 77:805–812PubMedCrossRef Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 77:805–812PubMedCrossRef
13.
Zurück zum Zitat Bosch JL (2005) The bion device: a minimally invasive implantable ministimulator for pudendal nerve neuromodulation in patients with detrusor overactivity incontinence. Urol Clin North Am 32:109–112PubMedCrossRef Bosch JL (2005) The bion device: a minimally invasive implantable ministimulator for pudendal nerve neuromodulation in patients with detrusor overactivity incontinence. Urol Clin North Am 32:109–112PubMedCrossRef
Metadaten
Titel
Long-term efficacy of electrical pudendal nerve stimulation for urgency–frequency syndrome in women
verfasst von
Siyou Wang
Shujing Zhang
Lin Zhao
Publikationsdatum
01.03.2014
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 3/2014
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-013-2223-7

Weitere Artikel der Ausgabe 3/2014

International Urogynecology Journal 3/2014 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.